Qiaojing Capital
Overview
Qiaojing Capital is a private equity and venture capital firm based in Shanghai, China, that focuses on investments in the healthcare, medical device, consumer, and technology, media, and telecommunications (TMT) sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EqualOcean | Mar 2016 | Series A Extension | Co-investor |
| Suzhou LungCare Medical Technology Co., Ltd. | - | Series A | Co-investor |
| Cygnus Biosciences (Beijing) Co., Ltd. | Jun 2018 | Series B Extension | Co-investor |
| Shanghai Vanxsoft Health Technology Co., Ltd. | Aug 2018 | Series A | Lead |
| Chengyi Family (橙意家人) | Feb 2017 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Qiaojing Capital based?
Qiaojing Capital is headquartered in Shanghai, China.
When was Qiaojing Capital founded?
Qiaojing Capital was founded in 2013.
How many portfolio companies does Qiaojing Capital have?
Qiaojing Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in Qiaojing Capital's portfolio?
Portfolio companies visible on Caplight include EqualOcean, Suzhou LungCare Medical Technology Co., Ltd., Cygnus Biosciences (Beijing) Co., Ltd., Shanghai Vanxsoft Health Technology Co., Ltd., Chengyi Family (橙意家人).
What was Qiaojing Capital's most recent investment shown here?
Qiaojing Capital's most recent investment in this portfolio sample was in Shanghai Vanxsoft Health Technology Co., Ltd. in 2018.
What sectors does Qiaojing Capital focus on?
Qiaojing Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, Media, Entertainment & Gaming, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Qiaojing Capital focus on?
Qiaojing Capital typically invests at the Early stage.